This inventor holds 1 USPTO granted patent. Top assignee: Jcr Pharmaceuticals Co., Ltd.. Active years: 1999.
Company Filing History:
Years Active: 1999
Title: Mitsuru Hirota: Innovator in Metastasis Suppression
Introduction
Mitsuru Hirota is a notable inventor based in Minowamura, Japan. He has made significant contributions to the field of medicine, particularly in the development of metastasis suppressory agents. His work focuses on creating treatments that are both effective and have a reduced level of toxicity.
Latest Patents
Hirota holds a patent for "Metastasis suppressory agents." This invention provides novel agents that include ursolic acid or its salt as an active ingredient. These agents can be administered orally or through injection, allowing patients to receive post-operative ambulatory treatment with minimized side effects.
Career Highlights
Hirota is associated with JCR Pharmaceuticals Co., Ltd., where he continues to innovate in the pharmaceutical industry. His dedication to improving patient care through effective treatments is evident in his research and development efforts.
Collaborations
Hirota has worked alongside talented colleagues, including Hiromichi Ishikawa and Tomoko Watanabe. Their collaborative efforts contribute to the advancement of medical treatments and innovations.
Conclusion
Mitsuru Hirota's work in developing metastasis suppressory agents showcases his commitment to enhancing patient care through innovative solutions. His contributions to the field of medicine are invaluable and continue to impact the lives of many.